Tavares et al.
1987
3′-Azido-3′-deoxythymidine in feline leukemia virus-infected cats: a model for therapy and prophylaxis of AIDS
Mervis et al.
1988
The gag gene products of human immunodeficiency virus type 1: alignment within the gag open reading frame, identification of posttranslational modifications, and evidence for alternative gag precursors
Kornbluth et al.
1989
Interferons and bacterial lipopolysaccharide protect macrophages from productive infection by human immunodeficiency virus in vitro.
Gavrilin et al.
2002
Methamphetamine enhances cell-associated feline immunodeficiency virus replication in astrocytes
Chesebro et al.
1988
Development of a sensitive quantitative focal assay for human immunodeficiency virus infectivity
Lazdins et al.
1991
In vitro effect of transforming growth factor-beta on progression of HIV-1 infection in primary mononuclear phagocytes
Hayashi et al.
1990
Cyclobut-A and cyclobut-G, carbocyclic oxetanocin analogs that inhibit the replication of human immunodeficiency virus in T cells and monocytes and macrophages in vitro
Rook et al.
1987
Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
CA1332687C
(en )
1994-10-25
Disinfectant and/or sanitizing cleaner compositions
Pluda et al.
1990
Development of non-Hodgkin lymphoma in a cohort of patients with severe human immunodeficiency virus (HIV) infection on long-term antiretroviral therapy
YAMAMOTO et al.
1991
Experimental vaccine protection against feline immunodeficiency virus
Pauza et al.
1990
Reinfection results in accumulation of unintegrated viral DNA in cytopathic and persistent human immunodeficiency virus type 1 infection of CEM cells.
DK176253B1
(da )
2007-04-30
Præparat, fremgangsmåde og kit til påvisning af antistoffer mod et humant retrovirus in vitro
SI9200297B
(sl )
2003-02-28
Antagonisti endotelinskih receptorjev
Zeidner et al.
1990
Alpha interferon (2b) in combination with zidovudine for the treatment of presymptomatic feline leukemia virus-induced immunodeficiency syndrome
DE1356047U
(cg-RX-API-DMAC7.html )
US4900548A
(en )
1990-02-13
Use of diethylcarbamazine to enhance antigen-antibody and antigen-host immune cell interactions
Craig et al.
1993
Antiviral synergy between inhibitors of HIV proteinase and reverse transcriptase
Cloyd et al.
2001
How does HIV cause depletion of CD4 lymphocytes? A mechanism involving virus signaling through its cellular receptors
Richman
1987
Dideoxynucleosides are less inhibitory in vitro against human immunodeficiency virus type 2 (HIV-2) than against HIV-1
Denis et al.
1994
Alveolar macrophages from subjects infected with HIV‐1 express macrophage inflammatory protein‐1α (MIP‐1α): contribution to the CD8+ alveolitis
Armand-Ugón et al.
2003
Reduced fitness of HIV-1 resistant to CXCR4 antagonists
Shapshak et al.
1991
HIV-1 propagates in human neuroblastoma cells
AU1266292A
(en )
1992-04-28
Method and compositions for diagnosing and treating chronic fatigue immunodysfunction syndrome
US5596018A
(en )
1997-01-21
Antiviral agents against aids-causing virus